RWML
MRNA icon

RAFFA WEALTH MANAGEMENT, LLC’s Moderna MRNA Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41K Buy
63
+13
+26% +$673 ﹤0.01% 620
2026
Q1 		$2.54K Buy
50
+2
+4% +$93 ﹤0.01% 690
2025
Q4 		$1.42K Buy
48
+1
+2% +$27 ﹤0.01% 838
2025
Q3 		$1.21K Buy
47
+16
+52% +$446 ﹤0.01% 843
2025
Q2 		$855 Hold
31
– – ﹤0.01% 908
2025
Q1 		$879 Sell
31
-12
-28% -$426 ﹤0.01% 860
2024
Q4 		$1.79K Sell
43
-230
-84% -$11K ﹤0.01% 699
2024
Q3 		$18.2K Buy
273
+130
+91% +$11.9K ﹤0.01% 234
2024
Q2 		$17K Buy
143
+100
+233% +$12.7K ﹤0.01% 356
2024
Q1 		$4.58K Hold
43
– – ﹤0.01% 522
2023
Q4 		$4.28K Hold
43
– – ﹤0.01% 422
2023
Q3 		$4.44K Hold
43
– – ﹤0.01% 401
2023
Q2 		$5.22K Hold
43
– – ﹤0.01% 385
2023
Q1 		$6.6K Buy
43
+2
+5% +$330 ﹤0.01% 350
2022
Q4 		$7.36K Hold
41
– – ﹤0.01% 327
2022
Q3 		$4.85K Hold
41
– – ﹤0.01% 395
2022
Q2 		$5.86K Hold
41
– – ﹤0.01% 354
2022
Q1 		$7.06K Sell
41
-3
-7% -$505 ﹤0.01% 339
2021
Q4 		$11.2K Buy
44
+2
+5% +$585 ﹤0.01% 286
2021
Q3 		$16.2K Buy
42
+10
+31% +$3.69K 0.01% 210
2021
Q2 		$7.52K Sell
32
-19
-37% -$3.4K ﹤0.01% 297
2021
Q1 		$6.44K Buy
51
+6
+13% +$869 ﹤0.01% 351
2020
Q4 		$4.7K Sell
45
-1
-2% -$101 ﹤0.01% 369
2020
Q3 		$3.25K Sell
46
-41
-47% -$2.86K ﹤0.01% 393
2020
Q2 		$5.59K Hold
87
– – ﹤0.01% 296
2020
Q1 		$2.61K Buy
+87
New +$2K ﹤0.01% 375

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's MRNA Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Moderna (MRNA) stake by 26% in Q2 2026, buying an estimated $673 and bringing the position to 63 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #620.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $18.2K in Q3 2024. 202 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 63 shares of Moderna worth $4.41K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 13 Moderna shares in Q2 2026, an estimated $673.
  • Moderna made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #620 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • RAFFA WEALTH MANAGEMENT, LLC's Moderna position peaked at $18.2K in Q3 2024.
  • 202 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.